57 related articles for article (PubMed ID: 2327077)
1. Complement-mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and complement receptors.
Robinson WE; Montefiori DC; Mitchell WM
Virology; 1990 Apr; 175(2):600-4. PubMed ID: 2327077
[TBL] [Abstract][Full Text] [Related]
2. Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis.
Thomas S; Smatti MK; Ouhtit A; Cyprian FS; Almaslamani MA; Thani AA; Yassine HM
Mol Immunol; 2022 Dec; 152():172-182. PubMed ID: 36371813
[TBL] [Abstract][Full Text] [Related]
3. Antibody dependent enhancement: Unavoidable problems in vaccine development.
Xu L; Ma Z; Li Y; Pang Z; Xiao S
Adv Immunol; 2021; 151():99-133. PubMed ID: 34656289
[TBL] [Abstract][Full Text] [Related]
4. Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.
Marasini B; Vyas HK; Lakhashe SK; Hariraju D; Akhtar A; Ratcliffe SJ; Ruprecht RM
AIDS; 2021 Dec; 35(15):2423-2432. PubMed ID: 34402452
[TBL] [Abstract][Full Text] [Related]
5. No Evidence for a Role for Antibodies during Vaccination-Induced Enhancement of Porcine Reproductive and Respiratory Syndrome.
Sautter CA; Trus I; Nauwynck H; Summerfield A
Viruses; 2019 Sep; 11(9):. PubMed ID: 31489915
[TBL] [Abstract][Full Text] [Related]
6. Viral-Induced Enhanced Disease Illness.
Smatti MK; Al Thani AA; Yassine HM
Front Microbiol; 2018; 9():2991. PubMed ID: 30568643
[TBL] [Abstract][Full Text] [Related]
7. Non-Neutralizing Antibodies Directed against HIV and Their Functions.
Mayr LM; Su B; Moog C
Front Immunol; 2017; 8():1590. PubMed ID: 29209323
[TBL] [Abstract][Full Text] [Related]
8. V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
Perez LG; Martinez DR; deCamp AC; Pinter A; Berman PW; Francis D; Sinangil F; Lee C; Greene K; Gao H; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Tartaglia J; O'Connell RJ; Robb ML; Michael NL; Kim JH; Gilbert P; Montefiori DC
PLoS One; 2017; 12(7):e0180720. PubMed ID: 28678869
[TBL] [Abstract][Full Text] [Related]
9. Relationship between Vaccine-Induced Antibody Capture of Infectious Virus and Infection Outcomes following Repeated Low-Dose Rectal Challenges with Simian Immunodeficiency Virus SIVmac251.
Gach JS; Venzon D; Vaccari M; Keele BF; Franchini G; Forthal DN
J Virol; 2016 Oct; 90(19):8487-95. PubMed ID: 27440881
[TBL] [Abstract][Full Text] [Related]
10. Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells.
Iankov ID; Penheiter AR; Griesmann GE; Carlson SK; Federspiel MJ; Galanis E
Virus Res; 2013 Mar; 172(1-2):15-23. PubMed ID: 23266401
[TBL] [Abstract][Full Text] [Related]
11. Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.
Özkaya Şahin G; Holmgren B; Sheik-Khalil E; da Silva Z; Nielsen J; Nowroozalizadeh S; Månsson F; Norrgren H; Aaby P; Fenyö EM; Jansson M
J Virol; 2013 Jan; 87(1):273-81. PubMed ID: 23077299
[TBL] [Abstract][Full Text] [Related]
12. Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.
Willey S; Aasa-Chapman MM; O'Farrell S; Pellegrino P; Williams I; Weiss RA; Neil SJ
Retrovirology; 2011 Mar; 8():16. PubMed ID: 21401915
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins.
Sheppard NC; Davies SL; Jeffs SA; Vieira SM; Sattentau QJ
Clin Vaccine Immunol; 2007 Feb; 14(2):157-67. PubMed ID: 17167037
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1.
Jakubik JJ; Saifuddin M; Takefman DM; Spear GT
Immunology; 1999 Apr; 96(4):612-9. PubMed ID: 10233749
[TBL] [Abstract][Full Text] [Related]
15. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.
Montefiori DC
Springer Semin Immunopathol; 1997; 18(3):371-90. PubMed ID: 9089955
[No Abstract] [Full Text] [Related]
16. Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.
Osiowy C; Horne D; Anderson R
Clin Diagn Lab Immunol; 1994 Nov; 1(6):670-7. PubMed ID: 8556519
[TBL] [Abstract][Full Text] [Related]
17. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).
Montefiori DC; Stewart K; Ahearn JM; Zhou J; Zhou J
J Virol; 1993 May; 67(5):2699-706. PubMed ID: 8474169
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of human immunodeficiency virus infection.
Levy JA
Microbiol Rev; 1993 Mar; 57(1):183-289. PubMed ID: 8464405
[TBL] [Abstract][Full Text] [Related]
19. Feline CD4 molecules expressed on feline non-lymphoid cell lines are not enough for productive infection of highly lymphotropic feline immunodeficiency virus isolates.
Norimine J; Miyazawa T; Kawaguchi Y; Tomonaga K; Shin YS; Toyosaki T; Kohmoto M; Niikura M; Tohya Y; Mikami T
Arch Virol; 1993; 130(1-2):171-8. PubMed ID: 8389115
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
